Heterogeneity and cellular hierarchy of lung cDC2

肺 cDC2 的异质性和细胞层次

基本信息

  • 批准号:
    10665348
  • 负责人:
  • 金额:
    $ 23.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-06 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Abstract Dendritic cells (DCs) play a fundamental role in bridging innate and adaptive immunity. Among DC subtypes, conventional DC2 (cDC2) are pivotal in multiple diseases including allergy, fungal & parasite infection, and cancer. However, studying cDC2 has been challenged by the small cell number and a lack of the subset- specific animal model. To better understand the characteristics and roles of cDC2 subsets, we have utilized the cutting-edge, RNA-based high-throughput transcriptomic profiling technique known as single cell RNA- sequencing (scRNA-seq). This approach has enabled us to better understand lung cDC2 in terms of diversity and cellular hierarchy. Our preliminary data indicate that lung cDC2 can be categorized into 6 distinct subsets. Of interest, lung CX3CR1hicDC2 subset are origin of rest of 5 subsets. In aim 1, we will test whether other lung cDC2 subsets are derived from the CX3CR1hicDC2 subset. In aim 2, we will test whether a cDC-specific CX3CR1 depletable stain (CX3CR1-DTRcDC) is responsible not only Th2 immunity but also Th17 immune responses. Successful completion of this project will provide us with a better understanding of heterogeneity and cellular dynamic lineage trajectory of lung cDC2. Moreover, our new mouse strain, cDC specific CX3CR1 depletable strain (CX3CR1-DTRcDC), will be a great asset to study cDC2-mediated diseases.
摘要 树突状细胞(Dendritic cells,DCs)在天然免疫和适应性免疫中起重要作用。在DC亚型中, 常规DC 2(cDC 2)在多种疾病中起关键作用,包括过敏、真菌和寄生虫感染, 癌然而,研究cDC 2受到了小细胞数量和缺乏亚群的挑战。 特定动物模型。为了更好地理解cDC 2亚群的特征和作用,我们利用了 尖端的,基于RNA的高通量转录组学分析技术,称为单细胞RNA- 测序(scRNA-seq)。这种方法使我们能够更好地了解肺cDC 2的多样性, 和细胞层次。 我们的初步数据表明,肺cDC 2可以分为6个不同的子集。感兴趣,龙哥 CX 3CR 1hicDC 2亚群是其余5个亚群的起源。在目标1中,我们将测试其他肺cDC 2亚群是否 来自CX 3CR 1hicDC 2亚群。在目标2中,我们将测试是否存在cDC特异性CX 3CR 1可耗竭性。 染色剂(CX 3CR 1-DTRcDC)不仅负责Th 2免疫,而且负责Th 17免疫应答。 这个项目的成功完成将使我们更好地了解异质性和细胞 肺cDC 2的动态谱系轨迹。此外,我们的新小鼠品系,cDC特异性CX 3CR 1耗竭 菌株CX 3CR 1-DTRcDC,将是研究cDC 2介导疾病的重要资产。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gye Young Park其他文献

Gye Young Park的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gye Young Park', 18)}}的其他基金

Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
CX3CR1巨噬细胞介导的嗜酸性过敏性肺部炎症消退机制
  • 批准号:
    10625350
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
  • 项目类别:
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
CX3CR1巨噬细胞介导的嗜酸性过敏性肺部炎症消退机制
  • 批准号:
    10210655
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
  • 项目类别:
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
CX3CR1巨噬细胞介导的嗜酸性过敏性肺部炎症消退机制
  • 批准号:
    10403559
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
  • 项目类别:
CSF1 Receptor-Mediated Tumor Microenvironment in Lung Cancer
CSF1 受体介导的肺癌肿瘤微环境
  • 批准号:
    10553138
  • 财政年份:
    2020
  • 资助金额:
    $ 23.99万
  • 项目类别:
CSF1 Receptor-Mediated Tumor Microenvironment in Lung Cancer
CSF1 受体介导的肺癌肿瘤微环境
  • 批准号:
    10376736
  • 财政年份:
    2020
  • 资助金额:
    $ 23.99万
  • 项目类别:
CSF1 Receptor-Mediated Tumor Microenvironment in Lung Cancer
CSF1 受体介导的肺癌肿瘤微环境
  • 批准号:
    9888672
  • 财政年份:
    2020
  • 资助金额:
    $ 23.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了